Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

Comprehensive analyses of cancer genomes promise to inform prognoses and precise cancer treatments. A major barrier, however, is inaccessibility of metastatic tissue. A potential solution is to characterize circulating tumor cells (CTCs), but this requires overcoming the challenges of isolating rare...

Full description

Bibliographic Details
Main Authors: Adalsteinsson, Viktor A. (Contributor), Tallapragada, Naren (Contributor), Tahirova, Narmin (Contributor), Regev, Aviv (Contributor), Love, John C (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Ragon Institute of MGH, MIT and Harvard (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Love, J. Christopher (Contributor)
Format: Article
Language:English
Published: Nature Publishing Group, 2014-11-07T14:37:43Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items